ScandiDos AB (OSTO:SDOS) ROE % Adjusted to Book Value: 0.92% (As of Apr. 2026)

ScandiDos AB OSTO:SDOS -1.23% 48 ROE % Adjusted to Book Value is 0.92% as of Apr. 2026. GuruFocus rates OSTO:SDOS with a GF Score™ of 48/100 and a GF Value™ of kr1.15 (Possible Value Trap). The stock has 4 warning signs investors should review.

ScandiDos AB's ROE % for the quarter that ended in Apr. 2026 was 1.23%. ScandiDos AB's PB Ratio for the quarter that ended in Apr. 2026 was 1.34. ScandiDos AB's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2026 was 0.92%.

ScandiDos AB ROE % Adjusted to Book Value Related Terms

ScandiDos AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for ScandiDos AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ScandiDos AB ROE % Adjusted to Book Value Chart

ScandiDos AB Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Apr25

Apr26

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.24

-9.76

-19.26

0.46

-5.92

ScandiDos AB Quarterly Data
	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26	Apr26
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-3.41	-11.10	1.94	-11.79	0.92

OSTO:SDOS vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, ScandiDos AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ScandiDos AB ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ScandiDos AB's ROE % Adjusted to Book Value falls into.

Save Embed

48GF Score

ScandiDos AB OSTO:SDOS

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ScandiDos AB ROE % Adjusted to Book Value Calculation

ScandiDos AB's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-7.93%	/	1.34
	=	-5.92%

ScandiDos AB's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.23%	/	1.34
	=	0.92%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 0.92% mean?

ScandiDos AB (OSTO:SDOS) has a ROE % Adjusted to Book Value of 0.92% as of Apr. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on ScandiDos AB and its competitors.

Is ScandiDos AB's ROE % Adjusted to Book Value too high?

ScandiDos AB's current ROE % Adjusted to Book Value is 0.92%. Overall, ScandiDos AB has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does ScandiDos AB's ROE % Adjusted to Book Value compare to ABT and SYK?

ScandiDos AB's ROE % Adjusted to Book Value of 0.92% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?

A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on ScandiDos AB and its competitors. ScandiDos AB's current ROE % Adjusted to Book Value is 0.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ScandiDos AB stock overvalued right now?

Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Possible Value Trap. The stock's GF Value™ is kr1.15, compared to a current price of kr0.80 — trading 30.4% below its estimated fair value. The current ROE % Adjusted to Book Value is 0.92%. ScandiDos AB's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current ROE % Adjusted to Book Value is 0.92% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?

Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued. The current stock price of kr0.80 is trading 30.4% below its estimated GF Value™ of kr1.15. GuruFocus considers ScandiDos AB to be Possible Value Trap.

Key valuation signals for OSTO:SDOS:

ROE % Adjusted to Book Value: 0.92%
GF Value™: kr1.15 vs. price of kr0.80 (30.4% below fair value)
GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ScandiDos AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:QLIFE XSAT:MONI XSAT:POLAR XSAT:PEXA B OSTO:PERP B XSAT:VSD B XSAT:REDS XSAT:ZENI OSTO:SPEC OSTO:NEOLA ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address Uppsala Science Park, Uppsala, SWE, SE-751 83

Website https://www.scandidos.com

ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.

48GF Score

Get the complete analysis for OSTO:SDOS

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.80

Price

kr1.15

GF Value

View OSTO:SDOS Analysis

See ROE % Adjusted to Book Value data for all stocks →